Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-10 @ 8:29 AM
Study NCT ID:
NCT04263051
Status:
COMPLETED
Last Update Posted:
2025-02-05
First Post:
2020-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-07
First Submit QC Date:
None
Study First Post Date:
2020-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-04
Last Update Post Date:
2025-02-05
Last Update Post Date Type:
ACTUAL